Tweet(function() { var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true; po.src = 'https://apis.google.com/js/plusone.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s); })();HemaQuest Pharmaceuticals, Inc. recently gained $13 million worth of extension funding for their Series B round. This additional financing was participated in by Aberdare Ventures, Forward Ventures, and Lilly Ventures. Other existing investors like [...]
Posted in Interviews, Lead411, Venture Financings | Also tagged Aberdare Ventures, biopharmaceutical company, De Novo Ventures, e-interview, extension funding, Forward Ventures, HemaQuest Pharmaceuticals, Inc., Latterell Venture Partners, Lead411, Lilly Ventures, revenue, series B funding, series b funding extension, Tamara Seymour, venture capital
HemaQuest Lands Series B Extension Funding Worth $13M